DMC Biotechnologies
Americas
Boulder
,
United States
Scaleup
FOUNDED
2014
HEADCOUNT
21-100
FUNDING
Series A
Keywords:
precision_fermentation, metabolic_engineering, nutraceuticals, specialty_chemicals, amino_acids
BUSINESS
DMC Biotechnologies is a Boulder, Colorado / Durham, North Carolina-based company founded in 2014, producing bio-based specialty chemicals via precision fermentation. Under new CEO Jim Flatt (appointed 2023), the company has focused on commercializing myo-inositol and D-chiro-inositol for supplements and L-alanine as a chemical intermediate. Formed a JV with Michelin, Danone, and Crédit Agricole in 2024.
BIOTECH INVOLVEMENT
Core; uses a Dynamic Metabolic Control fermentation platform and engineered strains to produce bio-based specialty chemicals and ingredients (nutraceuticals, cosmetics, industrial), with commercial-scale production via partners.
TECHNOLOGY PLATFORM
precision fermentation; Dynamic Metabolic Control
PRIMARY PRODUCTS
fermented D-chiro-inositol, myo-inositol, L-alanine